One in five adults said they experienced any symptoms of anxiety or depression in a 2-week period, according to a 2022 CDC ...

The FDA updated a warning on the label of esketamine nasal spray (Spravato) about the long-term cognitive and memory impairments that have been reported with ketamine misuse or abuse. New 3-year ...

Mental health is a vital aspect of overall well-being, especially for students who face unique pressures and challenges. From ...

He went for an appointment this week, only to find the clinic closed. "I do know some guys that take [es]ketamine for PTSD. It's helped them immensely." Veterans use the nasal spray esketamine to ...

When Dr. Husseini Manji was developing the first-in-class depression medication Spravato at Johnson & Johnson he encountered plenty of naysayers.

"This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers hope for the millions of people affected by TRD," he added. Analysts at ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

Amanda Gardner is a freelance health reporter whose stories have appeared in cnn.com, health.com, cnn.com, WebMD, HealthDay, Self Magazine, the New York Daily News, Teachers & Writers Magazine ...

That status goes to Johnson & Johnson's Spravato (esketamine), which was approved in March 2019 and is administered as a nasal spray twice a week for four weeks. However, it has a broader label as ...